Pick Your Community: | Hopkins | Muhlenberg | Daviess | Christian | Fayette | Henderson | Lakes | McCracken | Warren | Webster

Alzheimer's Disease Trial at UK First of its Kind Worldwide

elderly couple 300LEXINGTON, Ky. (12/8/13) – A new clinical trial being conducted at the University of Kentucky Sanders-Brown Center on Aging and the UK Alzheimer’s Disease Center may signal new hope in the future for those who might be afflicted with the devastating disease. Taking laboratory research pioneered at SBCoA and the associated UK ADC into human trials, the federally-funded research project will examine the therapeutic potential of microRNAs to delay or prevent Alzheimer’s disease.
 
Led by physician-scientist Dr. Gregory Jicha, and building off of the work of fellow SBCoA physician-scientist Dr. Peter Nelson, the project, formally titled “Modulation of micro-RNA pathways by gemfibrozil in pre-dementia Alzheimer disease,” will operate with a total budget of $1.5 million over three years. Funding was awarded by the National Institute on Aging as the result of a competitive process.
 
In 2006, the Nobel Prize was awarded for the discovery of microRNA biology. MicroRNAs are now understood by scientists to be implicated in health and disease states for hundreds of conditions. However, despite advances in microRNA technology, to date no group in the world has been able to apply microRNA discoveries in human clinical trials to affect neurodegenerative disease states.
 
“We are currently funded by the NIA/NIH and approved to take Dr. Pete Nelson's microRNA discoveries into the first-ever human clinical trial of microRNA modulation to influence a disease state. This trial is just starting, but it is not a hope or future expectation, it is real today,” said Jicha. “The microRNA project at the University of Kentucky is the first trial in the history of mankind to test the therapeutic potential of microRNAs in modulating neurodegenerative disease states. If our discovery is successful it will open the door for untold therapeutic developments for the diseases that plague us all as we age.”
 
As background, Jicha explained that, “Many have heard the speculation that more than 90 percent of our DNA is ‘junk’. The truth is that if we had ‘junk’, it would have been weeded out evolutionarily.”
 
In reality, at least some of this DNA codes for small fragments of RNA that regulate gene expression in health and disease states. These small RNA fragments are called microRNA. In previous work, Nelson of SBCoA has been able to show that one such microRNA is reduced in the brain very early as Alzheimer’s disease pathology begins.
 
“Nelson’s evidence suggests that if we can increase the levels of this microRNA, we may be able to prevent Alzheimer’s disease, or even stop it when it is in its earliest stages,” said Jicha.

Fortunately, a FDA-approved drug that can increase miRNA-107 levels already exists, and is currently approved for treating high cholesterol. In cell culture experiments this drug, called gemfibrozil, can prevent Alzheimer’s disease-associated changes.
 
Gemfibrozil is one of a class of drugs called fibrates, currently used worldwide to treat high cholesterol. Previous studies of people taking fibrates have consistently demonstrated an approximately 50 percent reduction in risk for Alzheimer’s disease.
 
“In U.S. terms,” said Jicha, “that could potentially cut the burden of Alzheimer’s from 5.4 million cases to 2.7 million nationwide.”
 
“This innovative clinical trial is a great example of the ‘bench to bedside’ focus of the UK Sanders-Brown Center on Aging – taking a research discovery made in the laboratory and translating that knowledge into a human clinical study. This pioneering clinical study testing the therapeutic potential of microRNAs to delay or prevent Alzheimer’s disease clearly shows how Pete Nelson and Greg Jicha, and the Sanders-Brown Center on Aging, are leading the world in testing promising new approaches to Alzheimer’s therapy,” said Linda Van Eldik, director of the Sanders-Brown Center on Aging.
 
Watch Dr. Jicha discuss the importance of clinical trials to Alzheimer's research below:

SurfKY News
Information provided by Allison Elliott-Shannon

© Copyright 2014 SurfKY News Group, Inc. All rights reserved. This material may not be published, broadcast, or rewritten without permission. SurfKY News encourages you to share this story by using one of the social media links below.

Most Read This Week (Site-Wide)

August 21, 2014 5566

Muhlenberg Task Force on Trail of Home…

in News by Wes Miller
August 18, 2014 4433

Man Injured in Early Morning WKP Accident

in Top Stories by Rita Dukes Smith, SurfKY News Director
August 18, 2014 4185

Owensboro Board of Commissioners…

in News by Beth Cecil
August 20, 2014 3976

Park Avenue Trespass Call Leads to…

in Top Stories by Madisonville Police Department
August 18, 2014 3975

Unlawful Solicitation

in News by Sgt. J.D. Winkler

Most Read Stories from Hopkins County

August 20, 2014 3976

Park Avenue Trespass Call Leads to…

in Top Stories by Madisonville Police Department
August 18, 2014 2700

Madisonville Man Charged for Shoplifting,…

in Top Stories by Madisonville Police Department
August 21, 2014 1901

Pedestrian Struck on East Arch Street,…

in Top Stories by Officer Ryan Clark
August 20, 2014 1668

Dawson Springs Woman Arrested for Driving…

in Top Stories by SurfKY News
August 18, 2014 1471

Madisonville Firefighters Recognized for…

in Top Stories by Rita Dukes Smith, SurfKY News Director

Most Read Stories from Owensboro

August 18, 2014 4185

Owensboro Board of Commissioners…

in News by Beth Cecil
August 18, 2014 3975

Unlawful Solicitation

in News by Sgt. J.D. Winkler
August 18, 2014 3848

RiverArtes Opening at OMFA

in News by Owensboro Museum of Fine Art
August 19, 2014 3322

Free Arthritis Exercise Program will be…

in News by Woody Maglinger
August 19, 2014 3239

Municipal Art Collection on Exhibit at…

in News by Mary Bryan Hood

Most Read Stories from Muhlenberg County

August 18, 2014 4433

Man Injured in Early Morning WKP Accident

in Top Stories by Rita Dukes Smith, SurfKY News Director
August 18, 2014 3871

Luke's Flea Market Vendors' Home Away…

in Top Stories by Charles W. Riley II, SurfKY News
August 18, 2014 3675

'How Dry I Was'

in Top Stories by Rita Dukes Smith, SurfKY News Director
August 19, 2014 3195

'Another One Bites the 'Duct'

in Top Stories by Paul McRee, SurfKY News
August 19, 2014 2560

Drakesboro Woman Injured When Tree Falls…

in Top Stories by Martha Clark

SurfKY News Group, Inc. Central Office & Printing Division
1125 Nebo Rd.  •  Madisonville, KY 42431  •  270.452.2249 (fax)
Main Number: 270.452.2727 (phone)  •  Printing Division Direct Line: 270.821.8600 (phone)

SurfKY Owensboro News Bureau
920 Frederica St. / Suite 210  •  Owensboro, KY 42301  •  270.683-8060 (phone)


Contact a member of our staff: www.surfky.com/contact
Copyright © 2014 SurfKY News Group, Inc.  •  Terms of Use  •  Site Map

social 03social 04social 22social 21social 06